You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR BENZACLIN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for BENZACLIN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01138514 ↗ Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels Completed Padagis LLC Phase 3 2009-10-01 The purpose of this study is to compare the efficacy and safety profiles of Perrigo Israel Pharmaceuticals, Ltd. Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel and Benzaclin® Topical Gel (Clindamycin- Benzoyl Peroxide Gel).
NCT01138514 ↗ Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels Completed Perrigo Company Phase 3 2009-10-01 The purpose of this study is to compare the efficacy and safety profiles of Perrigo Israel Pharmaceuticals, Ltd. Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel and Benzaclin® Topical Gel (Clindamycin- Benzoyl Peroxide Gel).
NCT01237821 ↗ Comparing OTC Acne Treatment to Prescription Regimen Completed Loreal USA N/A 2010-10-01 This research is being done to find out the safety and efficacy of two acne creams, Effaclar and Benzaclin when used twice daily with a topical retinoid. Effaclar and Benzaclin are FDA approved for the treatment of acne.
NCT01237821 ↗ Comparing OTC Acne Treatment to Prescription Regimen Completed Milton S. Hershey Medical Center N/A 2010-10-01 This research is being done to find out the safety and efficacy of two acne creams, Effaclar and Benzaclin when used twice daily with a topical retinoid. Effaclar and Benzaclin are FDA approved for the treatment of acne.
NCT02465632 ↗ To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris. Completed Glenmark Pharmaceuticals Ltd. India Phase 3 2015-04-01 This is a randomized, double-blind, multiple-site, placebo-controlled, parallel-group study, designed to compare the efficacy and safety of generic Clindamycin 1%/ Benzoyl peroxide 5% topical gel (Glenmark Generics, Ltd), and the marketed product BenzaClin® Topical Gel, Clindamycin 1%/ Benzoyl peroxide 5% (Valeant Pharmaceuticals, US) in the treatment of acne vulgaris.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for BENZACLIN

Condition Name

Condition Name for BENZACLIN
Intervention Trials
Acne Vulgaris 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for BENZACLIN
Intervention Trials
Acne Vulgaris 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for BENZACLIN

Trials by Country

Trials by Country for BENZACLIN
Location Trials
United States 8
Belize 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for BENZACLIN
Location Trials
Pennsylvania 2
New York 1
Tennessee 1
South Carolina 1
Kentucky 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for BENZACLIN

Clinical Trial Phase

Clinical Trial Phase for BENZACLIN
Clinical Trial Phase Trials
Phase 3 2
Phase 1 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for BENZACLIN
Clinical Trial Phase Trials
Completed 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BENZACLIN

Sponsor Name

Sponsor Name for BENZACLIN
Sponsor Trials
Padagis LLC 1
Perrigo Company 1
Loreal USA 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for BENZACLIN
Sponsor Trials
Industry 5
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.